CHD-loss promotes tumor heterogeneity, lineage plasticity and resistance to AR targeted therapy resistance

被引：0
|
作者：
Mu, P. [1 ]
机构：
[1] UT Southwestern Med Ctr, Mol Biol, Dallas, TX USA
来源：
EUROPEAN JOURNAL OF CANCER | 2020年 / 138卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
52
引用
收藏
页码：S22 / S23
页数：2
相关论文
共 50 条
  • [1] CHD1-loss confers AR targeted therapy resistance via promoting cancer heterogeneity and lineage plasticity
    Zhang, Zeda
    Zhou, Chuanli
    Li, Xiaoling
    Barnes, Spencer
    Deng, Su
    Hoover, Elizabeth
    Chen, Chi-Chao
    Lee, Young Sun
    Wang, Choushi
    Tirado, Carla
    Metang, Lauren
    Johnson, Nickolas
    Wongvipat, John
    Navrazhina, Kristina
    Cao, Zhen
    Abida, Wassim
    Lujambio, Amaia
    Li, Sheng
    Malladi, Vankat
    Sawyers, Charles
    Mu, Ping
    CANCER RESEARCH, 2020, 80 (16)
  • [2] CHD1-loss promotes tumor heterogeneity and therapy resistance in prostate cancer.
    Zhang, Zeda
    Zhou, Chuanli
    Li, Xiaoling
    Sawyers, Charles
    Mu, Ping
    CANCER RESEARCH, 2020, 80 (21)
  • [3] Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation
    Zhang, Zeda
    Zhou, Chuanli
    Li, Xiaoling
    Barnes, Spencer D.
    Deng, Su
    Hoover, Elizabeth
    Chen, Chi-Chao
    Lee, Young Sun
    Zhang, Yanxiao
    Wang, Choushi
    Metang, Lauren A.
    Wu, Chao
    Tirado, Carla Rodriguez
    Johnson, Nickolas A.
    Wongvipat, John
    Navrazhina, Kristina
    Cao, Zhen
    Choi, Danielle
    Huang, Chun-Hao
    Linton, Eliot
    Chen, Xiaoping
    Liang, Yupu
    Mason, Christopher E.
    de Stanchina, Elisa
    Abida, Wassim
    Lujambio, Amaia
    Li, Sheng
    Lowe, Scott W.
    Mendell, Joshua T.
    Malladi, Venkat S.
    Sawyers, Charles L.
    Mu, Ping
    CANCER CELL, 2020, 37 (04) : 584 - +
  • [4] Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer
    Li, Xiaoling
    Wang, Yunguan
    Deng, Su
    Zhu, Guanghui
    Wang, Choushi
    Johnson, Nickolas A.
    Zhang, Zeda
    Tirado, Carla Rodriguez
    Xu, Yaru
    Metang, Lauren A.
    Gonzalez, Julisa
    Mukherji, Atreyi
    Ye, Jianfeng
    Yang, Yuqiu
    Peng, Wei
    Tang, Yitao
    Hofstad, Mia
    Xie, Zhiqun
    Yoon, Heewon
    Chen, Liping
    Liu, Xihui
    Chen, Sujun
    Zhu, Hong
    Strand, Douglas
    Liang, Han
    Raj, Ganesh
    He, Housheng Hansen
    Mendell, Joshua T.
    Li, Bo
    Wang, Tao
    Mu, Ping
    CANCER CELL, 2023, 41 (08) : 1427 - +
  • [5] ZNF397 loss triggers TET2-driven epigenetic rewiring, lineage plasticity, and AR-targeted therapy resistance
    Mu, Ping
    Xu, Yaru
    Deng, Su
    CANCER RESEARCH, 2024, 84 (06)
  • [6] Genetic heterogeneity and transcriptional plasticity drive resistance during immunotherapy and targeted therapy
    Reinard Dummer
    Journal of Translational Medicine, 13 (Suppl 1)
  • [7] Genomically encoded lineage plasticity drives resistance to EGFR targeted therapy in lung adenocarcinoma
    Zatzman, Matthew
    Quintanal-Villalonga, Alvaro
    Salehi, Sohrab
    Falcon, Christina
    Ceglia, Nicholas
    Shah, Sohrab P.
    Rudin, Charles M.
    Yu, Helena A.
    CANCER RESEARCH, 2024, 84 (06)
  • [8] Abnormal alternative splicing promotes tumor resistance in targeted therapy and immunotherapy
    Deng, Kun
    Yao, Jingwei
    Huang, Jialu
    Ding, Yubo
    Zuo, Jianhong
    TRANSLATIONAL ONCOLOGY, 2021, 14 (06):
  • [9] Re: Loss of SYNCRIP Unleashes APOBEC-Driven Mutagenesis, Tumor Heterogeneity, and AR-Targeted Therapy Resistance in Prostate Cancer Editorial Comment
    Atala, Anthony
    JOURNAL OF UROLOGY, 2024, 211 (04): : 635 - 636
  • [10] The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance
    Beltran, Himisha
    Hruszkewycz, Andrew
    Scher, Howard I.
    Hildesheim, Jeffrey
    Isaacs, Jennifer
    Yu, Evan Y.
    Kelly, Kathleen
    Lin, Daniel
    Dicker, Adam
    Arnold, Julia
    Hecht, Toby
    Wicha, Max
    Sears, Rosalie
    Rowley, David
    White, Richard
    Gulley, James L.
    Lee, John
    Meco, Maria Diaz
    Small, Eric J.
    Shen, Michael
    Knudsen, Karen
    Goodrich, David W.
    Lotan, Tamara
    Zoubeidi, Amina
    Sawyers, Charles L.
    Rudin, Charles M.
    Loda, Massimo
    Thompson, Timothy
    Rubin, Mark A.
    Tawab-Amiri, Abdul
    Dahut, William
    Nelson, Peter S.
    CLINICAL CANCER RESEARCH, 2019, 25 (23) : 6916 - 6924
12345